JNJ-66525433 / J&J - LARVOL DELTA

A Study of JNJ-66525433 in Healthy Participants and Participants With Ulcerative Colitis (clinicaltrials.gov) - P1; N=82; Terminated; Sponsor: Janssen Research & Development, LLC; N=140 ➔ 82; Trial completion date: Jun 2023 ➔ Oct 2021; Recruiting ➔ Terminated; Trial primary completion date: Apr 2022 ➔ Oct 2021; Sponsor Decision.

Clinical • Enrollment change • Trial completion date • Trial primary completion date • Trial termination • Gastroenterology • Gastrointestinal Disorder • Immunology • Inflammatory Bowel Disease • Ulcerative Colitis

A Study of JNJ-66525433 in Healthy Participants and Participants With Ulcerative Colitis (clinicaltrials.gov) - P1; N=140; Recruiting; Sponsor: Janssen Research & Development, LLC; Trial completion date: Oct 2022 ➔ Jun 2023

Clinical • Trial completion date • Gastroenterology • Gastrointestinal Disorder • Immunology • Inflammatory Bowel Disease • Ulcerative Colitis

A Study of JNJ-66525433 in Healthy Participants and Participants With Ulcerative Colitis (clinicaltrials.gov) - P1; N=128; Recruiting; Sponsor: Janssen Research & Development, LLC; Trial completion date: Apr 2022 ➔ Oct 2022

Clinical • Trial completion date • Gastroenterology • Gastrointestinal Disorder • Immunology • Inflammatory Bowel Disease • Ulcerative Colitis

A Study of JNJ-66525433 in Healthy Participants and Participants With Ulcerative Colitis (clinicaltrials.gov) - P1; N=128; Recruiting; Sponsor: Janssen Research & Development, LLC; Not yet recruiting ➔ Recruiting

Clinical • Enrollment open • Gastroenterology • Gastrointestinal Disorder • Immunology • Inflammatory Bowel Disease • Ulcerative Colitis

A Study of JNJ-66525433 in Healthy Participants and Participants With Ulcerative Colitis (clinicaltrials.gov) - P1; N=128; Not yet recruiting; Sponsor: Janssen Research & Development, LLC

Clinical • New P1 trial • Gastroenterology • Gastrointestinal Disorder • Immunology • Inflammatory Bowel Disease • Ulcerative Colitis